test

A Phase III Randomized Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion (ECOG 1208)

Conditions

Liver

Trial Phase

Phase III

Trial Purpose and Description

Trial Purpose


Participation Guidelines

Age:
Gender:

Eligibility Criteria

Sponsor:
Eastern Cooperative Oncology Group
Dates:
04/07/2011
Last Updated:
Study HIC#:
1102008042